APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Neurostimulation Devices

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Selected research

Market Structure

Global Implantable Neurostimulation Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025188 pages

Choose your research edition.

Industry ResearchImplantable Neurostimulation Devices Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Neurostimulation Devices Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Implantable Neurostimulation Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Neurostimulation Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Neurostimulation Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Read the full market overview

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

This report provides an overview of the global Implantable Neurostimulation Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Implantable Neurostimulation Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Implantable Neurostimulation Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Implantable Neurostimulation Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Implantable Neurostimulation Devices Segment by Company

Medtronic

Boston Scientific

St. Jude Medical (Abbott)

LivaNova

Nevro

NeuroPace

Beijing Pins

Synapse Biomedical

Implantable Neurostimulation Devices Segment by Type

Spinal Cord Stimulation (SCS)

Gastric Electric Stimulation (GES)

Deep Brain Stimulation (DBS)

Sacral Nerve Stimulation (SNS)

Vagus Nerve Stimulation (VNS)

Others

Implantable Neurostimulation Devices Segment by Application

Pain Management

Parkinson's Disease

Urinary and Fecal Incontinence

Epilepsy

Gastroparesis

Others

Implantable Neurostimulation Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulation Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Neurostimulation Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Implantable Neurostimulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Implantable Neurostimulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Implantable Neurostimulation Devices Industry Trends Table 2. Implantable Neurostimulation Devices Industry Drivers Table 3. Implantable Neurostimulation Devices Industry Opportunities and Challenges Table 4. Implantable Neurostimulation Devices Industry Restraints Table 5. Global Implantable Neurostimulation Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Implantable Neurostimulation Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Implantable Neurostimulation Devices Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Implantable Neurostimulation Devices Sales Market Share by Manufacturers Table 9. Global Implantable Neurostimulation Devices Average Sales Price (K USD/Unit) of Manufacturers (2021-2026) Table 10. Global Implantable Neurostimulation Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Implantable Neurostimulation Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Implantable Neurostimulation Devices Manufacturers, Product Type & Application Table 13. Global Implantable Neurostimulation Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Implantable Neurostimulation Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Spinal Cord Stimulation (SCS) Table 17. Major Manufacturers of Gastric Electric Stimulation (GES) Table 18. Major Manufacturers of Deep Brain Stimulation (DBS) Table 19. Major Manufacturers of Sacral Nerve Stimulation (SNS) Table 20. Major Manufacturers of Vagus Nerve Stimulation (VNS) Table 21. Major Manufacturers of Others Table 22. Global Implantable Neurostimulation Devices Sales by Type 2021 VS 2025 VS 2032 (Units) Table 23. Global Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 24. Global Implantable Neurostimulation Devices Sales by Type (2027-2032) & (Units) Table 25. Global Implantable Neurostimulation Devices Sales Market Share by Type (2021-2026) Table 26. Global Implantable Neurostimulation Devices Sales Market Share by Type (2027-2032) Table 27. Global Implantable Neurostimulation Devices Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 28. Global Implantable Neurostimulation Devices Revenue by Type (2021-2026) & (Units) Table 29. Global Implantable Neurostimulation Devices Revenue by Type (2027-2032) & (Units) Table 30. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2021-2026) Table 31. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Pain Management Table 33. Major Manufacturers of Parkinson's Disease Table 34. Major Manufacturers of Urinary and Fecal Incontinence Table 35. Major Manufacturers of Epilepsy Table 36. Major Manufacturers of Gastroparesis Table 37. Major Manufacturers of Others Table 38. Global Implantable Neurostimulation Devices Sales by Application 2021 VS 2025 VS 2032 (Units) Table 39. Global Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 40. Global Implantable Neurostimulation Devices Sales by Application (2027-2032) & (Units) Table 41. Global Implantable Neurostimulation Devices Sales Market Share by Application (2021-2026) Table 42. Global Implantable Neurostimulation Devices Sales Market Share by Application (2027-2032) Table 43. Global Implantable Neurostimulation Devices Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 44. Global Implantable Neurostimulation Devices Revenue by Application (2021-2026) & (Units) Table 45. Global Implantable Neurostimulation Devices Revenue by Application (2027-2032) & (Units) Table 46. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2021-2026) Table 47. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2027-2032) Table 48. Global Implantable Neurostimulation Devices Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 49. Global Implantable Neurostimulation Devices Sales by Region (2021-2026) & (Units) Table 50. Global Implantable Neurostimulation Devices Sales Market Share by Region (2021-2026) Table 51. Global Implantable Neurostimulation Devices Sales Forecasted by Region (2027-2032) & (Units) Table 52. Global Implantable Neurostimulation Devices Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. North America Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 55. North America Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 56. Europe Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Europe Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 58. Europe Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 59. Asia Pacific Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 60. Asia Pacific Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 61. Asia Pacific Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 62. South America, Middle East and Africa Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 63. South America, Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 64. South America, Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 65. Global Implantable Neurostimulation Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Implantable Neurostimulation Devices Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Implantable Neurostimulation Devices Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Implantable Neurostimulation Devices Revenue Market Share by Region (2021-2026) Table 69. Global Implantable Neurostimulation Devices Revenue Market Share by Region (2027-2032) Table 70. Medtronic Company Information Table 71. Medtronic Business Overview Table 72. Medtronic Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Medtronic Implantable Neurostimulation Devices Product Portfolio Table 74. Medtronic Recent Development Table 75. Boston Scientific Company Information Table 76. Boston Scientific Business Overview Table 77. Boston Scientific Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Boston Scientific Implantable Neurostimulation Devices Product Portfolio Table 79. Boston Scientific Recent Development Table 80. St. Jude Medical (Abbott) Company Information Table 81. St. Jude Medical (Abbott) Business Overview Table 82. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio Table 84. St. Jude Medical (Abbott) Recent Development Table 85. LivaNova Company Information Table 86. LivaNova Business Overview Table 87. LivaNova Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. LivaNova Implantable Neurostimulation Devices Product Portfolio Table 89. LivaNova Recent Development Table 90. Nevro Company Information Table 91. Nevro Business Overview Table 92. Nevro Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Nevro Implantable Neurostimulation Devices Product Portfolio Table 94. Nevro Recent Development Table 95. NeuroPace Company Information Table 96. NeuroPace Business Overview Table 97. NeuroPace Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. NeuroPace Implantable Neurostimulation Devices Product Portfolio Table 99. NeuroPace Recent Development Table 100. Beijing Pins Company Information Table 101. Beijing Pins Business Overview Table 102. Beijing Pins Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Beijing Pins Implantable Neurostimulation Devices Product Portfolio Table 104. Beijing Pins Recent Development Table 105. Synapse Biomedical Company Information Table 106. Synapse Biomedical Business Overview Table 107. Synapse Biomedical Implantable Neurostimulation Devices Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio Table 109. Synapse Biomedical Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Implantable Neurostimulation Devices Distributors List Table 113. Implantable Neurostimulation Devices Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Implantable Neurostimulation Devices Product Image Figure 2. Global Implantable Neurostimulation Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Neurostimulation Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Implantable Neurostimulation Devices Sales (2021-2032) & (Units) Figure 5. Global Implantable Neurostimulation Devices Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Implantable Neurostimulation Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Spinal Cord Stimulation (SCS) Image Figure 9. Gastric Electric Stimulation (GES) Image Figure 10. Deep Brain Stimulation (DBS) Image Figure 11. Sacral Nerve Stimulation (SNS) Image Figure 12. Vagus Nerve Stimulation (VNS) Image Figure 13. Others Image Figure 14. Global Implantable Neurostimulation Devices Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 15. Global Implantable Neurostimulation Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Implantable Neurostimulation Devices Sales Market Share by Type (2021-2032) Figure 17. Global Implantable Neurostimulation Devices Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 18. Global Implantable Neurostimulation Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2021-2032) Figure 20. Pain Management Image Figure 21. Parkinson's Disease Image Figure 22. Urinary and Fecal Incontinence Image Figure 23. Epilepsy Image Figure 24. Gastroparesis Image Figure 25. Others Image Figure 26. Global Implantable Neurostimulation Devices Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 27. Global Implantable Neurostimulation Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Implantable Neurostimulation Devices Sales Market Share by Application (2021-2032) Figure 29. Global Implantable Neurostimulation Devices Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 30. Global Implantable Neurostimulation Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2021-2032) Figure 32. North America Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 33. North America Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 34. U.S. Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 35. Canada Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 36. Mexico Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 37. Europe Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 38. Europe Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 39. Germany Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 40. France Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 41. U.K. Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 42. Italy Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 43. Netherlands Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 44. Asia Pacific Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 45. Asia Pacific Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 46. China Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 47. Japan Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Korea Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 49. Southeast Asia Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 50. India Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 51. Australia Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 52. South America, Middle East and Africa Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 53. South America, Middle East and Africa Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 54. Brazil Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 55. South Africa Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 56. Saudi Arabia Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 57. Turkey Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 58. Argentina Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 59. UAE Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 60. Egypt Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 61. Chile Implantable Neurostimulation Devices Sales and Growth Rate (2021-2032) & (Units) Figure 62. Global Implantable Neurostimulation Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Implantable Neurostimulation Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Implantable Neurostimulation Devices Revenue (2021-2032) & (US$ Million) Figure 65. North America Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Implantable Neurostimulation Devices Revenue (2021-2032) & (US$ Million) Figure 67. Europe Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Implantable Neurostimulation Devices Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Implantable Neurostimulation Devices Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Implantable Neurostimulation Devices Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Implantable Neurostimulation Devices Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Others
Applications
  • Pain Management
  • Parkinson's Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Others
Companies covered
  • Medtronic
  • Boston Scientific
  • St. Jude Medical (Abbott)
  • LivaNova
  • Nevro
  • NeuroPace
  • Beijing Pins
  • Synapse Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Implantable Neurostimulation Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Implantable Neurostimulation Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Implantable Neurostimulation Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Implantable Neurostimulation Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Implantable Neurostimulation Devices Market Dynamics
  1. 2.1 Implantable Neurostimulation Devices Industry Trends
  2. 2.2 Implantable Neurostimulation Devices Industry Drivers
  3. 2.3 Implantable Neurostimulation Devices Industry Opportunities and Challenges
  4. 2.4 Implantable Neurostimulation Devices Industry Restraints
3 Implantable Neurostimulation Devices Market by Manufacturers
  1. 3.1 Global Implantable Neurostimulation Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Implantable Neurostimulation Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Implantable Neurostimulation Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Implantable Neurostimulation Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Implantable Neurostimulation Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Implantable Neurostimulation Devices Manufacturers, Product Type & Application
  7. 3.7 Global Implantable Neurostimulation Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Implantable Neurostimulation Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Implantable Neurostimulation Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Implantable Neurostimulation Devices Tier 1, Tier 2, and Tier 3
4 Implantable Neurostimulation Devices Market by Type
  1. 4.1 Implantable Neurostimulation Devices Type Introduction
  2. 4.1.1 Spinal Cord Stimulation (SCS)
  3. 4.1.2 Gastric Electric Stimulation (GES)
  4. 4.1.3 Deep Brain Stimulation (DBS)
  5. 4.1.4 Sacral Nerve Stimulation (SNS)
  6. 4.1.5 Vagus Nerve Stimulation (VNS)
  7. 4.1.6 Others
  8. 4.2 Global Implantable Neurostimulation Devices Sales by Type
  9. 4.2.1 Global Implantable Neurostimulation Devices Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Implantable Neurostimulation Devices Sales by Type (2021-2032)
  11. 4.2.3 Global Implantable Neurostimulation Devices Sales Market Share by Type (2021-2032)
  12. 4.3 Global Implantable Neurostimulation Devices Revenue by Type
  13. 4.3.1 Global Implantable Neurostimulation Devices Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Implantable Neurostimulation Devices Revenue by Type (2021-2032)
  15. 4.3.3 Global Implantable Neurostimulation Devices Revenue Market Share by Type (2021-2032)
5 Implantable Neurostimulation Devices Market by Application
  1. 5.1 Implantable Neurostimulation Devices Application Introduction
  2. 5.1.1 Pain Management
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Urinary and Fecal Incontinence
  5. 5.1.4 Epilepsy
  6. 5.1.5 Gastroparesis
  7. 5.1.6 Others
  8. 5.2 Global Implantable Neurostimulation Devices Sales by Application
  9. 5.2.1 Global Implantable Neurostimulation Devices Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Implantable Neurostimulation Devices Sales by Application (2021-2032)
  11. 5.2.3 Global Implantable Neurostimulation Devices Sales Market Share by Application (2021-2032)
  12. 5.3 Global Implantable Neurostimulation Devices Revenue by Application
  13. 5.3.1 Global Implantable Neurostimulation Devices Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Implantable Neurostimulation Devices Revenue by Application (2021-2032)
  15. 5.3.3 Global Implantable Neurostimulation Devices Revenue Market Share by Application (2021-2032)
6 Global Implantable Neurostimulation Devices Sales by Region
  1. 6.1 Global Implantable Neurostimulation Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Implantable Neurostimulation Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Implantable Neurostimulation Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Implantable Neurostimulation Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Implantable Neurostimulation Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Implantable Neurostimulation Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Implantable Neurostimulation Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Implantable Neurostimulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Implantable Neurostimulation Devices Revenue by Region
  1. 7.1 Global Implantable Neurostimulation Devices Revenue by Region
  2. 7.1.1 Global Implantable Neurostimulation Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Implantable Neurostimulation Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Implantable Neurostimulation Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Implantable Neurostimulation Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Implantable Neurostimulation Devices Revenue (2021-2032)
  8. 7.2.2 North America Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Implantable Neurostimulation Devices Revenue (2021-2032)
  11. 7.3.2 Europe Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Implantable Neurostimulation Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Implantable Neurostimulation Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Implantable Neurostimulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Implantable Neurostimulation Devices Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Implantable Neurostimulation Devices Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 St. Jude Medical (Abbott)
  14. 8.3.1 St. Jude Medical (Abbott) Company Information
  15. 8.3.2 St. Jude Medical (Abbott) Business Overview
  16. 8.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio
  18. 8.3.5 St. Jude Medical (Abbott) Recent Developments
  19. 8.4 LivaNova
  20. 8.4.1 LivaNova Company Information
  21. 8.4.2 LivaNova Business Overview
  22. 8.4.3 LivaNova Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LivaNova Implantable Neurostimulation Devices Product Portfolio
  24. 8.4.5 LivaNova Recent Developments
  25. 8.5 Nevro
  26. 8.5.1 Nevro Company Information
  27. 8.5.2 Nevro Business Overview
  28. 8.5.3 Nevro Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nevro Implantable Neurostimulation Devices Product Portfolio
  30. 8.5.5 Nevro Recent Developments
  31. 8.6 NeuroPace
  32. 8.6.1 NeuroPace Company Information
  33. 8.6.2 NeuroPace Business Overview
  34. 8.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NeuroPace Implantable Neurostimulation Devices Product Portfolio
  36. 8.6.5 NeuroPace Recent Developments
  37. 8.7 Beijing Pins
  38. 8.7.1 Beijing Pins Company Information
  39. 8.7.2 Beijing Pins Business Overview
  40. 8.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Pins Implantable Neurostimulation Devices Product Portfolio
  42. 8.7.5 Beijing Pins Recent Developments
  43. 8.8 Synapse Biomedical
  44. 8.8.1 Synapse Biomedical Company Information
  45. 8.8.2 Synapse Biomedical Business Overview
  46. 8.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio
  48. 8.8.5 Synapse Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Implantable Neurostimulation Devices Value Chain Analysis
  2. 9.1.1 Implantable Neurostimulation Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Implantable Neurostimulation Devices Production Mode & Process
  6. 9.2 Implantable Neurostimulation Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Implantable Neurostimulation Devices Distributors
  9. 9.2.3 Implantable Neurostimulation Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst